Skip to Main Content

Author Details

Goran Bajic
Icahn School of Medicine at Mount Sinai
2010
34
19
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38054729An <i>in vitro</i> experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.mBio2024
36689343Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk-Directed Antibody Response.Adv Healthc Mater2023
37342504Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses.Front Bioeng Biotechnol2023
37131698An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.bioRxiv2023
35150638Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.Cell Host Microbe2022
35467422Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain.mBio2022
35522723Recall of B cell memory depends on relative locations of prime and boost immunization.Sci Immunol2022
36314798Infant Antibody Repertoires during the First Two Years of Influenza Vaccination.mBio2022
33274930Antibodies That Engage the Hemagglutinin Receptor-Binding Site of Influenza B Viruses.ACS Infect Dis2021
33791696A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants.bioRxiv2021
33594359Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.bioRxiv2021
33758878The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.medRxiv2021
33758863Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.bioRxiv2021
34648356Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.Sci Immunol2021
34464596A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.Immunity2021
34417304A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.Proc Natl Acad Sci U S A2021
34117107Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b.J Immunol2021
34332650Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.Cell2021
31104946Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.Cell Host Microbe2019
31775042Follicular Dendritic Cells Modulate Germinal Center B Cell Diversity through FcγRIIB.Cell Rep2019
31100267Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.Cell2019
30837606Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies.Sci Rep2019
29255041Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.Proc Natl Acad Sci U S A2018
28841417Clonal Evolution of Autoreactive Germinal Centers.Cell2017
26876535The cationic peptide LL-37 binds Mac-1 (CD11b/CD18) with a low dissociation rate and promotes phagocytosis.Biochim Biophys Acta2016
27820604Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.Nat Med2016
27339893Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3.J Biol Chem2016
25839998Multiple low-affinity interactions support binding of human osteopontin to integrin αXβ2.Biochim Biophys Acta2015
26489954Complement activation, regulation, and molecular basis for complement-related diseases.EMBO J2015
23184394Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.Protein Sci2013
24065820Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3.Proc Natl Acad Sci U S A2013
22405014Architecture of a dodecameric bacterial replicative helicase.Structure2012
22074172The acid-tolerant L-arabinose isomerase from the mesophilic Shewanella sp. ANA-3 is highly active at low temperatures.Microb Cell Fact2011
20688514The acid tolerant L-arabinose isomerase from the food grade Lactobacillus sakei 23K is an attractive D-tagatose producer.Bioresour Technol2010
  • 1 - 34 of 34

Recommended Authors

Soumya G Remesh
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2014
Number of shared co-authors 4
Yi Shi
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2014
Number of shared co-authors 0
Natalia E Ketaren
The Rockefeller University
Career Start Year 2013
Number of shared co-authors 0
Nicholas Dambrauskas
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 3
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 1
Brian G Pierce
University of Maryland Institute for Bioscience and Biotechnology Research
Career Start Year 2005
Number of shared co-authors 0
Pavlo Gilchuk
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 6
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 2005
Number of shared co-authors 6
Franklin R Toapanta
University of Maryland School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 0
Chen Xu
University of Massachusetts Chan Medical School
Career Start Year 2003
Number of shared co-authors 0
Bjoern Peters
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 4
William D Martin
EpiVax Inc.
Career Start Year 2001
Number of shared co-authors 0
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 5
Mansun Law
The Scripps Research Institute
Career Start Year 1998
Number of shared co-authors 0
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 0
Pavel Strop
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Paul A Ramsland
College of Science, RMIT University
Career Start Year 1997
Number of shared co-authors 1
Vladimir Vigdorovich
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 1997
Number of shared co-authors 3
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 3
Jaume Pons
Pfizer Inc.
Career Start Year 1994
Number of shared co-authors 2
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 3
Leonard Moise
EpiVax Inc.
Career Start Year 1991
Number of shared co-authors 0
Anne S De Groot
University of Georgia
Career Start Year 1989
Number of shared co-authors 0
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year 1984
Number of shared co-authors 3
Martin S Zand
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 0
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 8
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 7
James E Crowe
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 6

Collaborators

Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Michael S Diamond
Washington University School of Medicine
Co-authored papers 2
Rita E Chen
Co-authored papers 2
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers 2
Michael S Seaman
Co-authored papers 2
Ana S Gonzalez-Reiche
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Donna Neuberg
Co-authored papers 2
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Yongfei Cai
Co-authored papers 2
Adrianus C M Boon
Co-authored papers 2
Bing Chen
Co-authored papers 2
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Co-authored papers 1
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Alba Escalera
Co-authored papers 1
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Rebecca L Pearl
University of Florida College of Public Health and Health Professions
Co-authored papers 1
Nadia Storm
Harvard Medical School
Co-authored papers 1
Marion Dejosez
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Paul J Utz
Co-authored papers 1
Keith Farrugia
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 1
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers 1
Yiren Qin
The First Affiliated Hospital of Soochow University
Co-authored papers 1
Thomas Kehrer
Co-authored papers 1
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Burcu Ayoglu
KTH - Royal Institute of Technology
Co-authored papers 1
Velmurugan Balaraman
College of Veterinary Medicine, Kansas State University
Co-authored papers 1
Release 1.2